Landau Jeffrey B Insider Trades

Insider Trading History

Track insider trading activity for Landau Jeffrey B. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $392k 123,237 shares
Last Trade
Aug 20, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14k 11,250 shares
$1.24
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $379k 119,056 shares
Last Trade
Aug 20, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.14k 4,181 shares
$1.23
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $0 0 shares
Last Trade
Aug 20, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$14k 11,250 shares
$1.24
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $350k 110,060 shares
Last Trade
Mar 19, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.7k 6,562 shares
$2.09
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $445k 140,000 shares
Last Trade
Jan 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235k 140,000 shares
$1.68
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $275k 86,622 shares
Last Trade
Dec 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.63k 4,077 shares
$1.38
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $35.8k 11,250 shares
Last Trade
Dec 17, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.9k 11,250 shares
$1.41
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $288k 90,699 shares
Last Trade
Dec 17, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$15.9k 11,250 shares
$1.41
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $243k 76,379 shares
Last Trade
Sep 22, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.35k 4,119 shares
$1.30
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $256k 80,498 shares
Last Trade
Sep 20, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.3k 11,250 shares
$1.36
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Financial Officer
Holding Value $220k 69,248 shares
Last Trade
Mar 16, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.92k 1,477 shares
$1.98
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $318k 100,000 shares
Last Trade
Feb 02, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$557k 215,000 shares
$2.59
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $71.6k 22,500 shares
Last Trade
Aug 10, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.8k 22,500 shares
$1.59
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $111k 34,931 shares
Last Trade
Jul 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$16.9k 11,250 shares
$1.50
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $97.7k 30,725 shares
Last Trade
Jul 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.97k 4,206 shares
$1.42
$3.18
CytomX Therapeutics
CytomX Therapeutics CTMX
Chief Business Officer
Holding Value $59.3k 18,641 shares
Last Trade
Mar 23, 2022 Sale
$1.22M 425,144 shares
$2.88
$3.18

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up